NEW YORK – Diagnostics firm Proteomics International (PIL) plans to launch its proteomic test for endometriosis in Australia in the first half of the year with a US launch to follow shortly thereafter.
The test could be a non invasive tool used to improve detection of the condition, which currently takes an average of 7.5 years to diagnose, said Richard Lipscombe, managing director of the Nedlands, Australia-based firm.